Podcast
ASCO Daily News
Hosted by American Society of Clinical Oncology (ASCO) · EN
The ASCO Daily News Podcast features oncologists discussing the latest research and therapies in their areas of expertise.
40episodes
Episodes
Newest firstAll episodes
GLP-1 Receptor Agonists in GI Cancers: Hype or Promise?
4d ago00:18:15Tap to summarizeDr. Monty Pal and Dr. Rachna Shroff explore how GLP-1 receptor agonists impact progression and survival in GI cancers, examining current retrospective data, immune microenvironment biology, and the need for prospective trials. LINK TO FULL TRANSCRIPT
Transcribe →From Abstract to Action: Translating ASCO26 Research Into Global Practice
3w ago00:24:38Tap to summarizeHow do we translate oncology breakthroughs into practice? In part one of a two-part miniseries, host Dr. Monty Pal and Dr. Atul Batra discuss the clinical realities, opportunities, and challenges of adapting ASCO26 Plenary findings into cancer care worldwide, using India's health care landscape as a blueprint for resource-limited settings. LINK TO FULL TRANSCRIPT
Transcribe →Liquid Biopsy, AI, and Other Global Innovations From 2026 ASCO Breakthrough
Jul 900:22:30Tap to summarizeDr. Monty Pal and Dr. Roselle De Guzman discuss key abstracts from the 2026 ASCO Breakthrough Meeting, including the real-world impact of liquid biopsies for early multi-cancer detection, AI applications in colorectal cancer screening, and how global advances in breast, esophageal, and small cell lung cancers translate directly to diverse patient populations in the Asia-Pacific region. LINK TO FULL TRANSCRIPT
Transcribe →Breast Cancer Highlights From ASCO26: OPTIMA, lidERA, and VIKTORIA-1
Jun 3000:24:37Tap to summarizeDr. Megan Kruse and Dr. Hope Rugo discuss practice-changing data in metastatic breast cancer and critical shifts in the treatment of early-stage disease that were presented at the 2026 ASCO Annual Meeting. LINK TO FULL TRANSCRIPT
Transcribe →GU Cancer Highlights From ASCO26: PROTEUS, TALAPRO-3, and RAMPART
Jun 2500:30:28Tap to summarizeDr. Neeraj Agarwal and Dr. Jeanny Aragon-Ching discuss high-impact abstracts in the treatment of prostate, bladder, and kidney cancers that were presented at the 2026 ASCO Annual Meeting. LINK TO FULL TRANSCRIPT
Transcribe →Immunotherapy Highlights From ASCO26: Cellular Therapy, Melanoma, and Skin Cancers
Jun 2400:29:43Tap to summarizeDr. Pauline Funchain and Dr. Allison Betof discuss practice-changing and paradigm-shifting abstracts in melanoma, Merkel cell carcinoma, and cellular therapies that were presented at the 2026 ASCO Annual Meeting. LINK TO FULL TRANSCRIPT
Transcribe →GI Cancer Highlights From ASCO26: RASolute-302, BREAKWATER, and More
Jun 2300:22:46Tap to summarizeDr. Nilo Azad and Dr. Aparna Parikh discuss high-impact studies in gastrointestinal cancers and other novel treatment approaches that were presented at the 2026 ASCO Annual Meeting. LINK TO FULL TRANSCRIPT
Transcribe →Hematologic Cancer Highlights From ASCO26: MajesTEC-9, frontMIND, and More
Jun 1900:25:05Tap to summarizeDr. Marc Braunstein and Dr. Adam Kittai highlight top research on hematologic malignancies from the 2026 ASCO Annual Meeting, including studies on lymphoid malignancies, multiple myeloma, and plasma cell disorders. LINK TO FULL TRANSCRIPT
Transcribe →Lung Cancer Highlights From ASCO26: HARMONi-6, LIBRETTO-436, and More
Jun 1800:22:54Tap to summarizeDr. Christine Lovly and Dr. Vamsi Velcheti discuss practice-changing lung cancer data presented at the 2026 ASCO Annual Meeting, including key studies on squamous cell lung cancer, NSCLC, and SCLC. LINK TO FULL TRANSCRIPT
Transcribe →Day 5: Top Takeaways From ASCO26
Jun 200:09:35Tap to summarizeDr. Monty Pal shares highlights from the final day of ASCO26, including new research on treating anemia in myelofibrosis, advances in RAS-mutated mCRC, novel therapies for AML, and a potentially practice-changing trial in TNBC. LINK TO FULL TRANSCRIPT
Transcribe →